Vest Financial’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.13M Buy
24,740
+163
+0.7% +$21.5K 0.03% 303
2026
Q1
$3.43M Buy
24,577
+1,728
+8% +$242K 0.04% 282
2025
Q4
$2.8M Buy
22,849
+2,358
+12% +$287K 0.04% 291
2025
Q3
$2.27M Buy
20,491
+6,019
+42% +$684K 0.03% 292
2025
Q2
$1.6M Buy
14,472
+4,080
+39% +$434K 0.02% 302
2025
Q1
$1.16M Buy
10,392
+4,403
+74% +$454K 0.02% 305
2024
Q4
$553K Buy
5,989
+762
+15% +$68.6K 0.01% 257
2024
Q3
$438K Buy
+5,227
New +$399K 0.01% 261

Other funds holding GILD

Vest Financial's GILD Position: Q2 2026 in Review

Vest Financial increased its Gilead Sciences (GILD) stake by 0.66% in Q2 2026, buying an estimated $21.5K and bringing the position to 24,740 shares worth $3.13M. The position accounts for 0.03% of the portfolio, ranked #303.

Vest Financial first reported a position in GILD in Q3 2024 and has held it in 8 quarters since. The position peaked at $3.43M in Q1 2026. 1,032 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Vest Financial held 24,740 shares of Gilead Sciences worth $3.13M as of Q2 2026.
  • Vest Financial bought 163 Gilead Sciences shares in Q2 2026, an estimated $21.5K.
  • Gilead Sciences made up 0.03% of Vest Financial's portfolio in Q2 2026, its #303 holding.
  • Vest Financial first reported a position in Gilead Sciences in Q3 2024 and has held it in 8 quarters since.
  • Vest Financial's Gilead Sciences position peaked at $3.43M in Q1 2026.
  • 1,032 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Vest Financial's 13F filing for Q2 2026, filed 24 Jul 2026.